Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 92.70%
March 31, 2026 91.74%
December 31, 2025 90.73%
September 30, 2025 91.93%
June 30, 2025 92.98%
March 31, 2025 91.95%
December 31, 2024 93.34%
September 30, 2024 92.24%
June 30, 2024 92.01%
March 31, 2024 91.14%
December 31, 2023 90.27%
September 30, 2023 90.76%
June 30, 2023 95.20%
March 31, 2023 88.71%
December 31, 2022 88.15%
September 30, 2022 88.84%
June 30, 2022 87.56%
March 31, 2022 86.69%
December 31, 2021 82.81%
September 30, 2021 84.21%
June 30, 2021 82.87%
March 31, 2021 85.17%
December 31, 2020 85.25%
September 30, 2020 85.98%
Date Value
June 30, 2020 91.39%
March 31, 2020 79.21%
December 31, 2019 54.31%
September 30, 2019 82.60%
June 30, 2019 65.10%
March 31, 2019 72.14%
December 31, 2018 34.65%
September 30, 2018 93.45%
June 30, 2018 68.64%
March 31, 2018 82.27%
December 31, 2017 67.18%
September 30, 2017 96.07%
June 30, 2017 88.89%
March 31, 2017 93.92%
December 31, 2016 94.41%
September 30, 2016 94.96%
June 30, 2016 95.55%
March 31, 2016 95.54%
December 31, 2015 99.71%
September 30, 2015 97.27%
June 30, 2015 96.35%
March 31, 2015 98.50%
December 31, 2014 99.55%
September 30, 2014 99.28%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Orexo AB -137.1%
Swedencare AB 7.63%
Moberg Pharma AB 65.36%
Infant Bacterial Therapeutics AB --
AstraZeneca PLC 76.09%

Gross Profit Margin (Quarterly) Related Metrics